PATENT CLAIM ANALYSIS

Application Number: 15905483
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "234100"]

Abstract:
The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can reduce the amount of antigen which is required to achieve a particular immune response.

Claim (Index 12):
The composition of  claim 1 , wherein the TLR agonist is one of compounds 1 to 102 as defined in reference 13, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.17647
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15163592', '13790948', '14420238', '15887203', '15093652']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8089920879096965
- 35 USC 102 Novelty (BERT): 0.5954203264224708
- Combined Prediction Score: 0.7876349117609739
- Mean Citation Score: 476.229698
- Max Citation Score: 533.11896
- Similarity Product: 457.3483418209076

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test